Spanish Agency of Medicines and Medical Devices - Regulatory authority for pharmaceuticals in Spain
显示 2025 年的审批记录
仅限当前页。暂不支持搜索完整审批数据集。
药物名称 | 公司 | 适应症 | 日期 | 类型 |
|---|---|---|---|---|
| LANREOTIDA ZENTIVA 90 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA EFG | Zentiva K.S. | Diagnóstico Hospitalario | Aug 6, 2026 | Standard |
| CENRIFKI 60 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | Sanofi Winthrop Industrie | Uso Hospitalario | Aug 6, 2026 | Standard |
| SAPROPTERINA ELC 100 MG COMPRIMIDOS SOLUBLES EFG | Elc Group S.R.O. | Medicamento Sujeto A Prescripción Médica | Aug 6, 2026 | Standard |
| TRAMADOL/DEXKETOPROFENO AUROVITAS 75 MG/25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | Aurovitas Spain, S.A.U. | Medicamento Sujeto A Prescripción Médica | Aug 6, 2026 | Standard |
| LANREOTIDA ZENTIVA 120 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA EFG | Zentiva K.S. | Diagnóstico Hospitalario | Aug 6, 2026 | Standard |
| LANREOTIDA ZENTIVA 60 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA EFG | Zentiva K.S. | Diagnóstico Hospitalario | Aug 6, 2026 | Standard |
| RUXOLITINIB CIPLA 20 MG COMPRIMIDOS EFG | Cipla Europe N.V. | Diagnóstico Hospitalario | Aug 5, 2026 | Standard |
| RUXOLITINIB CIPLA 5 MG COMPRIMIDOS EFG | Cipla Europe N.V. | Diagnóstico Hospitalario | Aug 5, 2026 | Standard |
| RUXOLITINIB CIPLA 10 MG COMPRIMIDOS EFG | Cipla Europe N.V. | Diagnóstico Hospitalario | Aug 5, 2026 | Standard |
| APIXABAN NEWLINE PHARMA 5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | Newline Pharma S.L.U. | Medicamento Sujeto A Prescripción Médica | Aug 5, 2026 | Standard |
| LENVATINIB ACCORD 4 MG CAPSULAS DURAS EFG | Accord Healthcare S.L.U. | Diagnóstico Hospitalario | Aug 5, 2026 | Standard |
| RUXOLITINIB CIPLA 15 MG COMPRIMIDOS EFG | Cipla Europe N.V. | Diagnóstico Hospitalario | Aug 5, 2026 | Standard |
| LENVATINIB ACCORD 10 MG CAPSULAS DURAS EFG | Accord Healthcare S.L.U. | Diagnóstico Hospitalario | Aug 5, 2026 | Standard |
| QUETIAPINA VIATRIS PHARMACEUTICALS 50 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG | Viatris Pharmaceuticals S.L. | Medicamento Sujeto A Prescripción Médica | Aug 4, 2026 | Standard |
| RUXOLITINIB SANDOZ 15 MG COMPRIMIDOS EFG | Sandoz Farmaceutica S.A. | Diagnóstico Hospitalario | Aug 4, 2026 | Standard |
| RUXOLITINIB SANDOZ 20 MG COMPRIMIDOS EFG | Sandoz Farmaceutica S.A. | Diagnóstico Hospitalario | Aug 4, 2026 | Standard |
| TRAMADOL RETARD SUN 100 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG | Sun Pharmaceutical Industries (Europe) B.V. | Medicamento Sujeto A Prescripción Médica | Aug 4, 2026 | Standard |
| METSUNIX 50 MG/1.000 MG COMPRIMIDOS DE LIBERACION MODIFICADA | Adamed Pharma S.A. | Medicamento Sujeto A Prescripción Médica | Aug 4, 2026 | Standard |
| QUETIAPINA VIATRIS PHARMACEUTICALS 300 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG | Viatris Pharmaceuticals S.L. | Medicamento Sujeto A Prescripción Médica | Aug 4, 2026 | Standard |
| QUETIAPINA VIATRIS PHARMACEUTICALS 400 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG | Viatris Pharmaceuticals S.L. | Medicamento Sujeto A Prescripción Médica | Aug 4, 2026 | Standard |
